EGFR-Mutant Non-Small Cell Lung Cancer
EGFR-Mutant Non-Small Cell Lung Cancer is a type of lung cancer characterized by mutations in the EGFR gene, which can affect how the cancer grows and responds to treatment.
EGFR-Mutant Non-Small Cell Lung Cancer: BG-60366 Study
We are investigating a new treatment for patients with EGFR-mutant non-small cell lung cancer. The study will help us understand its safety and how well it works against the cancer.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitaetsklinikum Ulm AöR
Comprehensive Cancer Center Ulm (CCCU), Early clinical trials unit
Klingenstein, Germany
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
Oncolocy-Hematology Department
Bologna, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
UOC Fase 1
La Massimina-Casal Lumbroso, Italy
Sponsor: BeOne Medicines AG
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.